Mirabaud Asset Management’s AbbVie ABBV Stock Holding History

Mirabaud Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.95M	Sell	11,588 -13,457	-54%	-$2.9M	2.45%	13
2026 Q1	$5.34M	Buy	25,045 +9,636	+63%	+$2.14M	4.4%	11
2025 Q4	$2.96M	Buy	15,409 +5,131	+50%	+$1.17M	1.37%	25
2025 Q3	$2.29M	Sell	10,278 -1,054	-9%	-$215K	1.11%	25
2025 Q2	$2.07M	Sell	11,332 -668	-6%	-$124K	0.96%	27
2025 Q1	$2.46M	Sell	12,000 -4,801	-29%	-$933K	1.29%	26
2024 Q4	$2.96M	Hold	16,801	–	–	1.38%	23
2024 Q3	$3.27M	Buy	16,801 +7,726	+85%	+$1.44M	1.35%	28
2024 Q2	$1.56M	Sell	9,075 -110	-1%	-$18.2K	0.72%	34
2024 Q1	$1.67M	Buy	+9,185	New	+$1.58M	0.68%	32

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mirabaud Asset Management's ABBV Position: Q2 2026 in Review

Mirabaud Asset Management reduced its AbbVie (ABBV) stake by 54% in Q2 2026, selling an estimated $2.9M and leaving 11,588 shares worth $2.95M. The position accounts for 2.45% of the portfolio, ranked #13.

Mirabaud Asset Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.34M in Q1 2026. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Mirabaud Asset Management held 11,588 shares of AbbVie worth $2.95M as of Q2 2026.
Mirabaud Asset Management sold 13,457 AbbVie shares in Q2 2026, an estimated $2.9M.
AbbVie made up 2.45% of Mirabaud Asset Management's portfolio in Q2 2026, its #13 holding.
Mirabaud Asset Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
Mirabaud Asset Management's AbbVie position peaked at $5.34M in Q1 2026.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mirabaud Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.